6. Hot: Transcatheter Mitral Valve Replacement
With TAVR generating so much buzz, transcatheter mitral valve replacement devices appear to be the next cardiovascular technology. Abbott Laboratories, Edwards Lifesciences, and Medtronic each poured hundreds of millions of dollars into acquiring early-stage companies with technology in the space. Mitral valve disease is the most prevalent valve disease in the world, according to Abbott, which expects a multibillion-dollar market for the technology over the next 10 years. Ultimately, the market share size for mitral valve replacement technology could be double the size of the TAVR market, owing to the larger patient population. The Neovasc Tiara technology is shown here.